<DOC>
	<DOCNO>NCT01942122</DOCNO>
	<brief_summary>This 3-arm , prospective , randomize , double-blind , control study DLBS1442 treatment pain patient suspect endometriosis . It hypothesize reduction composite-pain intensity ( measure VAS ) baseline end study ( week 8th ) result administration DLBS1442 , regardless dosage regimen , significantly great Control . In addition , administration DLBS1442 high dose also result significantly great reduction DLBS1442 low dose Control .</brief_summary>
	<brief_title>DLBS1442 The Treatment Pain Patients Suspected Endometriosis</brief_title>
	<detailed_description>There three group treatment dosage regimen study . Eligible subject randomize receive follow regimen : 1 ) DLBS1442 dose 3 x 100 mg daily , 2 ) DLBS1442 dose 3 x 200 mg daily ; 3 ) mefenamic acid dose 3 x 500 mg daily . DLBS1442 take every day along study period ( 8 week ) , mefenamic acid take five ( 5 ) day menstrual period , i.e . day 1st day 5th menstrual period . Study treatment give standardize start point subject , i.e . first day respective menstrual period . Clinical laboratory examination evaluate investigational drug 's efficacy safety perform baseline every 4-week interval throughout study period .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Mefenamic Acid</mesh_term>
	<criteria>Signed informed consent trial related activity Female 18 50 year age Subjects suspect cystic endometriosis adenomyosis confirm transvaginal ultrasonography ( transrectal ultrasonography unmarried subject ) Presence moderate severe pain show VAS score least 4 least one follow pain : menstrual pain ( dysmenorrhea ) , dyspareunia , nonmenstrual pelvic pain , dysuria , dyschezia Occurrence least 3 last sequential menstrual cycle 21 35 day duration prior screening Pregnancy Patients infertility willing pregnant Using hormonal contraception form hormonal therapy within last 30 day Being therapy systemic corticosteroid chronic regular basis within last 90 day History presence suspect malignancy abnormality History surgical treatment endometriosis within 3 month prior screen History hysterectomy oophorectomy Presence clinical sign sexually transmit disease Presence unexplained uterine cervical bleeding Impaired liver function : serum ALT &gt; 2.5 time upper limit normal Impaired renal function : serum creatinine &gt; = 1.5 time upper limit normal Known suspect allergy similar product</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>DLBS1442</keyword>
	<keyword>Endometriosis</keyword>
	<keyword>Pain</keyword>
	<keyword>Visual Analogue Scale</keyword>
	<keyword>Endometriosis Health Profile ( EHP-30TM )</keyword>
</DOC>